Merrimack Pharmaceuticals GAAP EPS of -$0.04 (NASDAQ:MACK)
Merrimack Pharmaceuticals press release (MACK): Q2 GAAP EPS of -$0.04.As of June 30, 2022, Merrimack had cash and cash equivalents of $13.4 million, compared to $14.2 million as…
Merrimack Pharmaceuticals GAAP EPS of -$0.04 (NASDAQ:MACK)
Merrimack Pharmaceuticals press release (MACK): Q2 GAAP EPS of -$0.04.As of June 30, 2022, Merrimack had cash and cash equivalents of $13.4 million, compared to $14.2 million as…